Ország: Dél-afrikai Köztársaság
Nyelv: angol
Forrás: South African Health Products Regulatory Authority (SAHPRA)
Adcock Ingram Limited
See ingredients
GRANULES
EACH SACHET CONTAINS FOSFOMYCIN TROMETAMOL EQUIVALENT TO 3 g FOSFOMYCIN
Registered
1994-01-09
1 LABELLING - PATIENT INFORMATION LEAFLET The under-mentioned information with regard to this medicine shall appear on the patient information leaflet. The information shall be presented in the format stipulated, provided that the Council may authorise any deviation from such information or such format (Refer to Regulation 10 of the Act). 1. Scheduling status 2. Proprietary name and dosage form 3. Composition of the medicine, that is, what this medicine contains 4. Approved indication and use, that is, what this medicine is used for 5. Instruction before taking the medicine (refer to the Guidelines) 6. Instructions on how to take this medicine (refer to Guidelines) 7. Side effects {refer to Guidelines) 8. Storage and disposal information (refer to Guidelines) 9. Presentation 10. Identification 11. Registration number 12. Name and business address of the holder of the certificate of registration 13. Date of publication of the Patient Information Leaflet Please note that the proposed Patient Information Leaflet is based on the proposed Package Insert. A separate submission of the proposed Patient Information Leaflet has been made to the Clinical Unit for evaluation of the clinical aspects. The proposed patient information leaflet has been included in this MRF1 update for assessment of the pharmaceutical aspects thereof. 2 PLEASE READ THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. KEEP THIS LEAFLET. YOU MAY NEED TO READ IT AGAIN. IF YOU HAVE FURTHER QUESTIONS, PLEASE ASK YOUR DOCTOR OR YOUR PHARMACIST. THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU PERSONALLY AND YOU SHOULD NOT SHARE YOUR MEDICINE WITH OTHER PEOPLE. IT MAY HARM THEM, EVEN IF THEIR SYMPTOMS ARE THE SAME AS YOURS. SCHEDULING STATUS: PROPRIETARY NAME AND DOSAGE FORM: URIZONE 2G AND 3G (GRANULES) Fosfomycin trometamol equivalent to 2g or 3g of Fosfomycin base. 1. WHAT URIZONE CONTAINS: This medicine contains the active ingredient fosfomycin trometamol. URIZONE 2G: Each sachet contains 3,754g fosfomycin trometamol equivalent to fosfomycin 2g. C Olvassa el a teljes dokumentumot
1 SCHEDULING STATUS: PROPRIETARY NAME: URIZONE 2 G and 3 G GRANULES (AND DOSAGE FORM): GRANULES COMPOSITION: URIZONE 2 G: Each sachet contains 3,754 g fosfomycin trometamol equivalent to fosfomycin 2 g. Contains sugar: 2,100 g sucrose per sachet. URIZONE 3 G: Each sachet contains 5,631 g fosfomycin trometamol equivalent to fosfomycin 3 g. Contains sugar: 2,213 g sucrose per sachet. PHARMACOLOGICAL CLASSIFICATION: A.20.1.1 Broad & Medium Spectrum Antibiotics PHARMACOLOGICAL ACTION: Fosfomycin trometamol is a broad-spectrum bactericidal antibiotic, derived from phosphonic acid with activity in the lower urinary tract. The antibacterial activity of fosfomycin is due to an inhibition of bacterial cell wall synthesis. Its particular mechanism of action is inhibition of enol pyruvyl transferase. Fosfomycin is active _in vitro_ against species of Gram-positive and Gram-negative bacteria most frequently isolated in urinary tract infections (E. Coli, Proteus, Klebsiella, Enterobacter, Staphylococcus, Streptococcus). In vitro sensitivity does not necessarily imply _in vivo_ efficacy. 2 Fosfomycin trometamol is an orally well-absorbed salt of fosfomycin. It usually provides therapeutic concentrations of the active moiety in the urine for periods of thirty-six hours or more from a single dose. Fosfomycin is eliminated mainly unchanged through the kidneys and this results in very high peak urinary concentrations (approx. 3000 mg/I) within two to four hours. Therapeutic concentrations in urine are usually maintained for at least thirty-six hours. Food delays and reduces absorption of fosfomycin trometamol, resulting in reduced blood and urinary concentrations. In patients with moderately reduced renal function (creatinine clearance> 80 ml/min). including the physiological reduction in the elderly, the half-life of fosfomycin is prolonged but urinary concentration remains therapeutically adequate. INDICATIONS: URIZONE is indicated as a single dose in the treatment of acute uncomplicated lower urinary tract infections caused by Olvassa el a teljes dokumentumot